The IPO provides substantial capital for R&D and operations. Monitor the stock's trading debut for volatility and initial market reception. The governance changes, particularly the classified board and forum selection provisions, may affect future shareholder activism and litigation risks.
Price Chart
Executive Summary
Kailera Therapeutics completed its IPO on April 20, 2026, raising $718.8 million by selling 44,921,875 shares at $16.00 per share. Concurrently, the company amended its certificate of incorporation and bylaws to implement corporate governance changes required for public listing, including a classified board, removal of prior preferred stock, and updated stockholder meeting procedures.
Key Facts
- Completed IPO of 44,921,875 shares at $16.00 per share
- Raised $718.8 million in gross proceeds
- Amended certificate of incorporation to authorize 800 million common shares and 10 million undesignated preferred shares
- Implemented classified board structure with staggered three-year terms
- Eliminated previous series of preferred stock
- Adopted advance notice provisions for stockholder proposals and director nominations
Financial Impact
$718.8 million in gross proceeds from IPO at $16.00 per share
Risk Factors
- Execution risk in deploying raised capital effectively
- Potential share price volatility post-IPO
- Governance provisions may deter activist investors
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-164040 |
| Document: d137434dex31.htm | 0001193125-26-164040 |
| Document: d137434d8k.htm | 0001193125-26-164040 |
| Document: 0001193125-26-164040-index-headers.html | 0001193125-26-164040 |
| Document: 0001193125-26-164040-index.html | 0001193125-26-164040 |
| Document: 0001193125-26-164040.txt | 0001193125-26-164040 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access